Mitochondrial donation lineage disclosure obligations

Introduction

Mitochondrial donation is an assisted-reproduction technique in which nuclear genetic material from intended parents is combined with donor mitochondria to prevent the transmission of certain mitochondrial diseases. Because mitochondrial DNA is generally inherited through the maternal line, mitochondrial donation can create a distinctive three-person genetic contribution: nuclear DNA from the intended parents and mitochondrial DNA from a donor.

This creates an important legal question concerning lineage disclosure. A person born following mitochondrial donation may have legitimate interests in knowing that mitochondrial donor material contributed to their genetic makeup. At the same time, donors may have privacy interests, and parents may have concerns regarding family privacy and disclosure.

The legal challenge is therefore to balance the child's right to identity-related information, donor privacy, parental autonomy, medical interests, and confidentiality.

Nature of mitochondrial lineage information

Mitochondrial donation does not mean that the donor contributes the majority of the child's nuclear genetic inheritance. Rather, the donor supplies mitochondrial genetic material while nuclear DNA comes from the intended parents.

Nevertheless, mitochondrial DNA can have medical and genealogical significance. Knowledge of the mitochondrial donor may be relevant to understanding inherited health risks and family medical history.

Lineage disclosure should therefore distinguish between:

• Disclosure that mitochondrial donation occurred.
• Disclosure of the donor's identity.
• Disclosure of medical and genetic information about the donor.
• Disclosure of identifying information to descendants.
• Disclosure to healthcare professionals where medically necessary.

These categories need not be governed by identical rules.

Child's right to identity

A strong argument for disclosure arises from the child's interest in knowing relevant information concerning their biological origins. This interest can be particularly important where genetic information has medical significance.

The United Nations Convention on the Rights of the Child (CRC) provides relevant principles. Article 7 recognizes a child's right, as far as possible, to know and be cared for by their parents. Article 8 protects preservation of identity.

Although the Convention does not specifically address mitochondrial donation, its identity principles provide a useful international framework for considering donor-conception information.

Privacy of mitochondrial donors

Donors also possess legitimate privacy interests. Disclosure of their identity may expose them to unwanted contact, family consequences, or disclosure of their own genetic information.

A regulatory framework must therefore establish whether donors participate under:

• Anonymous donation.
• Identity-release arrangements.
• Conditional disclosure.
• Fully identifiable donation.

The legal rules applicable at the time of donation are particularly important. Changing the legal status of donor anonymity retrospectively may raise fairness and reliance concerns.

Indian constitutional privacy

The Supreme Court's decision in Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) provides an important constitutional foundation.

The Court recognized privacy as a fundamental right connected with dignity and personal autonomy. Genetic and reproductive information can fall within the sphere of informational and decisional privacy.

Accordingly, both donor and donor-conceived individual may possess legitimate privacy interests. Neither interest should automatically override the other without considering the specific circumstances.

Medical information and disclosure

Mitochondrial donation creates a particularly strong justification for preserving medically relevant information. Even where donor identity remains confidential, a person born following mitochondrial donation may need access to relevant medical information concerning mitochondrial health.

A regulatory framework should therefore distinguish identity disclosure from medical disclosure.

For example, an individual might be entitled to obtain clinically relevant information concerning mitochondrial disease without necessarily receiving the donor's name or contact details.

Comparative example: United Kingdom

The United Kingdom provides an important comparative model because mitochondrial donation has been legally regulated there.

The Human Fertilisation and Embryology Act 1990, as amended, provides the statutory foundation for assisted reproduction and mitochondrial donation regulation through the Human Fertilisation and Embryology Authority (HFEA).

The United Kingdom's donor-information framework demonstrates the possibility of separating identifying information from non-identifying information and medical information. The precise rights depend on the applicable regulatory rules and the circumstances of conception.

This model illustrates why disclosure regulation should be carefully structured rather than simply categorized as either complete secrecy or unrestricted disclosure.

European human-rights jurisprudence

The European Court of Human Rights has recognized that information concerning personal identity and biological origins can fall within the scope of private life under Article 8 of the European Convention on Human Rights.

In Mikulić v. Croatia (2002), the Court considered a person's interest in establishing biological parentage and recognized the importance of personal identity and family-origin information.

In Jäggi v. Switzerland (2006), the Court considered the importance of biological origins in the context of post-mortem DNA testing. The case illustrates that information about biological origins can constitute a significant aspect of personal identity.

Although neither case concerns mitochondrial donation specifically, their reasoning is relevant to lineage disclosure.

Disclosure and the best interests of the child

A central governance principle should be the best interests of the child. Where mitochondrial information has medical significance, withholding it could potentially interfere with the individual's ability to understand relevant health risks.

At the same time, disclosure should be structured to protect the donor from unnecessary exposure.

A balanced system could therefore provide:

1. Confirmation that mitochondrial donation occurred.
2. Relevant non-identifying medical information.
3. Updated medically significant information when necessary.
4. Identifying information at a legally specified age, where the regulatory model permits it.
5. Appropriate counseling before disclosure.
6. Privacy protections for both donor and recipient.

Consent and donor expectations

Donor consent should clearly explain the future disclosure framework. A donor should understand whether a donor-conceived person may eventually obtain identifying information.

This is particularly important because genetic technologies make anonymity increasingly difficult. Even if a formal database is confidential, consumer genetic-testing services and genealogical databases can sometimes make genetic relationships discoverable.

Consequently, regulators should avoid promising absolute lifelong anonymity where technology makes such anonymity practically uncertain.

Record preservation

Lineage disclosure rights are meaningless if records are destroyed. Fertility clinics and regulatory authorities should therefore maintain reliable records concerning:

• Donor identity.
• Relevant medical history.
• Mitochondrial genetic information.
• Consent arrangements.
• Date and circumstances of donation.
• Applicable disclosure rights.

Long-term record preservation is particularly important because mitochondrial lineage information may become medically relevant decades after birth.

Remedies and accountability

Healthcare providers and fertility institutions should be accountable for unlawful disclosure, negligent recordkeeping, destruction of required information, or failure to communicate medically significant information.

Potential remedies may include:

• Access to records.
• Correction of inaccurate information.
• Compensation where legally available.
• Regulatory sanctions.
• Professional disciplinary action.
• Court orders requiring preservation or disclosure.

Conclusion

Mitochondrial donation creates a distinctive lineage-disclosure problem because it combines assisted reproduction, genetic inheritance, donor privacy, and medical information. The most appropriate legal framework should recognize that the fact of mitochondrial donation, medical information, and donor identity are separate categories of information requiring potentially different disclosure rules.

Indian constitutional privacy principles from Puttaswamy v. Union of India (2017) provide a foundation for balancing reproductive autonomy and genetic privacy. Comparative jurisprudence such as Mikulić v. Croatia (2002) and Jäggi v. Switzerland (2006) demonstrates the legal importance of information concerning biological origins. The United Kingdom's mitochondrial-donation framework further illustrates how statutory regulation can establish structured donor-information rules.

Ultimately, mitochondrial lineage disclosure governance should be based on the child's best interests, identity interests, medical necessity, donor privacy, informed consent, secure long-term recordkeeping, and proportionate disclosure mechanisms. A well-designed system should preserve the individual's ability to understand their genetic and medical origins without unnecessarily compromising the legitimate privacy of mitochondrial donors.